HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sven Hauke Selected Research
Sven Hauke Research Topics
Disease
8
Neoplasms (Cancer)
11/2020 - 05/2002
3
Breast Neoplasms (Breast Cancer)
11/2020 - 10/2016
1
Urinary Bladder Neoplasms (Bladder Cancer)
04/2015
1
Lung Neoplasms (Lung Cancer)
11/2013
1
Genetic Translocation (Chromosomal Translocation)
01/2013
1
Hyperplasia
04/2008
1
Squamous Cell Carcinoma of Head and Neck
04/2008
1
Carcinogenesis
04/2008
1
Keratosis
04/2008
1
Oral Leukoplakia
04/2008
1
Hypoxia (Hypoxemia)
04/2005
1
Atherosclerotic Plaque (Atheroma)
01/2005
1
Osteosarcoma (Osteogenic Sarcoma)
03/2004
1
Sarcoma (Soft Tissue Sarcoma)
03/2004
1
Leiomyoma (Uterine Fibroids)
05/2002
1
Lipoma (Lipomata)
05/2002
1
Hamartoma
05/2002
Drug/Important Bio-Agent (IBA)
5
Proteins (Proteins, Gene)
FDA Link
05/2016 - 05/2002
2
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
11/2020 - 04/2015
2
HMGB1 Protein (HMG1)
IBA
04/2005 - 03/2004
1
Phenobarbital (Luminal)
FDA Link
11/2020
1
Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)
IBA
11/2020
1
human ERBB2 protein
IBA
10/2016
1
Biomarkers (Surrogate Marker)
IBA
11/2013
1
Tyrosine Kinase Inhibitors
IBA
11/2013
1
Anaplastic Lymphoma Kinase
IBA
11/2013
1
Microtubule-Associated Proteins (Microtubule-Associated Protein 2)
IBA
11/2013
1
Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)
IBA
01/2013
1
DNA (Deoxyribonucleic Acid)
IBA
01/2013
1
Formaldehyde (Formol)
FDA Link
01/2013
1
Paraffin
IBA
01/2013
1
Platelet-Derived Growth Factor
IBA
01/2013
1
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
01/2013
1
Collagen Type I (Type I Collagen)
IBA
01/2013
1
5'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)
IBA
04/2008
1
Carcinogens
IBA
04/2008
1
Histidine (L-Histidine)
FDA Link
04/2008
1
Oxygen (Dioxygen)
IBA
04/2005
1
DNA Adducts
IBA
03/2004
1
Cisplatin (Platino)
FDA Link
Generic
03/2004
Therapy/Procedure
3
Therapeutics
10/2017 - 03/2004